FGFR1 and neoplasm: Targeted DNA NGS of the tumor tissue identified two FGFR1 mutations, c.1972A>C p.T658P and c.1968G>C p.K656N, both located within the FGFR1 kinase domain and representing the sole pathogenic mutations.